Table 2.
Patient and Clinicopathologic Characteristics by Race
| Characteristic | White |
Black |
Other |
p |
|---|---|---|---|---|
| N = 74,807 | N = 6416 | N = 1369 | ||
| Age, y (median, IQR) | 65 (58–72) | 64 (57–71) | 67 (59–73) | <0.0001 |
| Time to treatment, d | 13 (6–24) | 14 (6–28) | 15 (2–27) | <0.0001 |
| Age, y | <0.0001 | |||
| 40 to <65 | 34,907 (46.7) | 3369 (52.5) | 555 (40.5) | |
| 65 to <75 | 26,386 (35.3) | 2052 (32.0) | 513 (37.5) | |
| 75 to <80 | 8188 (11.0) | 603 (9.4) | 181 (13.2) | |
| ≥80 | 5326 (7.1) | 392 (6.1) | 120 (8.8) | |
| Sex | <0.0001 | |||
| Male | 38,494 (51.5) | 3254 (50.7) | 915 (66.8) | |
| Female | 36,313 (48.5) | 3162 (49.3) | 454 (33.2) | |
| Hispanic origin | <0.0001 | |||
| Non-Hispanic | 73,074 (97.7) | 6364 (99.2) | 1272 (92.9) | |
| Hispanic | 1733 (2.3) | 52 (0.81) | 97 (7.1) | |
| Insurance status | <0.0001 | |||
| Private | 23,775 (31.8) | 1521 (23.7) | 374 (27.3) | |
| Medicare | 40,097 (53.6) | 3222 (50.2) | 665 (48.6) | |
| Medicaid | 6369 (8.5) | 1091 (17.0) | 218 (15.9) | |
| Other government insurance | 1200 (1.6) | 109 (1.7) | 41 (3.0) | |
| Uninsured | 3366 (4.5) | 473 (7.4) | 71 (5.2) | |
| Median household income, $ | <0.0001 | |||
| <30,000 | 10,390 (13.9) | 2543 (39.6) | 211 (15.4) | |
| 30,000–34,999 | 15,812 (21.1) | 1446 (22.5) | 203 (14.8) | |
| 35,000–45,999 | 23,242 (31.1) | 1404 (21.9) | 343 (25.1) | |
| >46,000 | 25,363 (33.9) | 1023 (15.9) | 612 (44.7) | |
| Education (% with no HS degree) | <0.0001 | |||
| ≥29 | 13,027 (17.4) | 2751 (42.9) | 281 (20.5) | |
| 20–28.9 | 20,292 (27.1) | 1997 (31.1) | 357 (26.1) | |
| 14–19.9 | 19,677 (26.3) | 900 (14.0) | 257 (18.8) | |
| <14 | 21,811 (29.2) | 768 (12.0) | 474 (34.6) | |
| Year of diagnosis | <0.0001 | |||
| 2004–2006 | 13,444 (18.0) | 1029 (16.0) | 188 (13.7) | |
| 2007–2009 | 15,508 (20.7) | 1296 (20.2) | 259 (18.9) | |
| 2010–2012 | 18,788 (25.1) | 1623 (25.3) | 336 (24.5) | |
| 2013–2016 | 27,067 (36.2) | 2468 (38.5) | 586 (42.8) | |
| CCS | 0.001 | |||
| 0 | 41,813 (55.9) | 3564 (55.6) | 814 (59.5) | |
| 1 | 21,870 (29.2) | 1809 (28.2) | 378 (27.6) | |
| ≥2 | 11,124 (14.9) | 1043 (16.3) | 177 (12.9) | |
| Facility type | <0.0001 | |||
| CP | 9951 (13.3) | 540 (8.4) | 155 (11.3) | |
| Comprehensive CP | 35,537 (47.5) | 2169 (33.8) | 519 (37.9) | |
| Academic and research program | 18,838 (25.2) | 2773 (43.2) | 532 (38.9) | |
| Integrated Network Cancer Program | 10,481 (14.0) | 934 (14.6) | 163 (11.9) | |
| Treatment at >1 facility | <0.0001 | |||
| No | 67,037 (89.6) | 5858 (91.3) | 1251 (91.4) | |
| Yes | 7770 (10.4) | 558 (8.7) | 118 (8.6) |
Note: Values are given in number (%) unless indicated otherwise.
CCS, Charlson-Deyo Comorbidity Score; CP, community program; HS, high school; IQR, interquartile range.